title: [Fungal infections in hematology patients and after blood stem cell transplantation: prophylaxis and treatment].
abstract: Patients with prolonged neutropenia or immunosuppression after stem cell transplantation are at a high risk of developing invasive fungal infections. Antimycotic prophylaxis is used to reduce the associated morbidity and mortality. The following classes of antimycotic agents are currently available: azoles (e.g., fluconazole, itraconazole, posaconazole), echinocandins (caspofungin, micafungin), and amphotericin B.
authors.affiliation: Medizinische Klinik Abt. V Hämatologie, Onkologie und Rheumatologie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Deutschland, gerlinde.egerer@med.uni-heidelberg.de.
authors.forename: G
authors.initials: G
authors.lastname: Egerer
authors.forename: T
authors.initials: T
authors.lastname: Schmitt
mesh_terms: D000935:Antifungal Agents / Q000008:administration & dosage*; D015331:Cohort Studies; D005858:Germany; D018380:Hematopoietic Stem Cell Transplantation; D017052:Hospital Mortality; D006801:Humans; D007938:Leukemia / Q000150:complications* / Q000401:mortality / Q000628:therapy; D008223:Lymphoma / Q000150:complications* / Q000401:mortality / Q000628:therapy; D009101:Multiple Myeloma / Q000150:complications* / Q000401:mortality / Q000628:therapy; D009181:Mycoses / Q000401:mortality / Q000517:prevention & control*; D009503:Neutropenia / Q000150:complications; D009894:Opportunistic Infections / Q000401:mortality / Q000517:prevention & control*
chemical_list: D000935:Antifungal Agents